ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135077; 2) Community: the network communities that were significantly associated with the response to NSC 135077; 3) Molecule: the relationships between components within communities and NSC 135077; 4) MDR: the compounds that were significantly associated with the NSC 135077.

NSC Compound Enrichment Correlation
NSC 135880 Null 0.00426229108513044 0.42659087
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.00426229108513044 0.23818751
NSC 18805 .gamma.-Thujaplicine 0.00426229108513044 0.3040586
NSC 300289 Pinafide 0.00426229108513044 0.36716268
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.00426229108513044 0.41900519
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.00426229108513044 0.49100651
NSC 619030 Analog of CC-1065 0.00426229108513044 0.31272769
NSC 637505 Null 0.00426229108513044 0.29035349
NSC 642324 Null 0.00426229108513044 0.49832007
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.00426229108513044 0.31857068
Total:126  Current:22    [First] [Prev] [Next] [Last]